Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Biomaterials|November 28, 2012
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancersJianqin Lu, Yixian Huang, Wenchen Zhao, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistanceJianqin Lu, Wenchen Zhao, Hao Liu, et al.Elife|October 11, 2017
Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vesselsJerome Robert, Emily B Button, Brian Yuen, et al.Bioconjugate Chemistry|June 12, 2012
PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxelYixian Huang, Jianqin Lu, Xiang Gao, et al.Therapeutic Advances in Respiratory Disease|April 30, 2021
A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertensionJames C Coons, Karryn Crisamore, Solomon Adams, et al.Molecular Pharmaceutics|September 30, 2014
Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrierJianqin Lu, Wenchen Zhao, Yixian Huang, et al.Pharmaceutical Research|July 31, 2013
Identification of three novel natural product compounds that activate PXR and CAR and inhibit inflammationSuticha Kittayaruksakul, Wenchen Zhao, Meishu Xu, et al.Acta Biomaterialia|July 17, 2016
A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxelJingjing Sun, Yichao Chen, Ke Li, et al.The British Journal of Ophthalmology|October 13, 2022
Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trialShengsong Xu, Zhouyue Li, Wenchen Zhao, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 15, 2017
Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapyJingjing Sun, Yanhua Liu, Yichao Chen, et al.Pageof 7